Evotec SE (EVT)
SIX
Closed
Aug 21, 2026
Day's Range
3.2052 wk Range
3.20Overview - EVT - Evotec SE
Key Statistics
Valuation
Enterprise Value
542.21M
P/E (Trailing)
‪-5.52‬
PEG Ratio
‪-0.01‬
Price / Sales (TTM)
‪1.11‬
Price / Book
‪1.26‬
EV / EBITDA
‪-7.91‬
Profitability
Gross Margin
‪-1.00%‬
Profit Margin
‪-27.47%‬
Operating Margin
‪-62.25%‬
Return on Assets
‪-5.39%‬
Return on Equity
‪-26.07%‬
Ownership
Shares Outstanding
177.59M
Float
135.38M
Held by Insiders
‪9.96%‬
Held by Institutions
‪61.24%‬
Price stats
Beta
‪1.26‬
50-Day Avg
‪4.52‬
200-Day Avg
‪4.80‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - EVT - Evotec SE
Peers - EVT - Evotec SE
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on SIX.
- EVTSIXEvotec SE569.33MMarket Cap-52.81%52-week change-5.52P/E (Trailing)‪-27.47%‬Profit Margin
- MRKSIXMerck & Co., Inc.284.44BMarket Cap+32.03%52-week change32.58P/E (Trailing)‪13.58%‬Profit Margin
- CLSIXColgate-Palmolive Company57.83BMarket Cap+7.24%52-week change33.38P/E (Trailing)‪9.68%‬Profit Margin
- MERSIXMerck KGaA56.73BMarket Cap+8.66%52-week change23.07P/E (Trailing)‪11.21%‬Profit Margin
- GALDSIXGalderma Group AG40.00BMarket Cap+20.04%52-week change58.75P/E (Trailing)‪14.57%‬Profit Margin
- SDZSIXSandoz Group AG31.95BMarket Cap+30.88%52-week change63.11P/E (Trailing)‪5.53%‬Profit Margin
- SFZNSIXSiegfried Holding AG3.51BMarket Cap-7.04%52-week change20.58P/E (Trailing)‪12.77%‬Profit Margin
Profile Summary - EVT - Evotec SE
About
Evotec SE is a drug discovery company that specializes in platform-based solutions for pharmaceutical and biotechnology collaborators worldwide. Operating through two main segments—EVT Execute and EVT Innovate—the company provides integrated drug discovery services on a fee-for-service basis, supplemented by…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
